Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald B Vender

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cutaneous Medicine and Surgery|February 6, 2007
Miliarial gout (a new entity)Rahul Shukla, Ronald B Vender, Ayman Alhabeeb, et al.
Journal of the American Academy of Dermatology|June 19, 2007
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapyMichael M Jiaravuthisan, Denis Sasseville, Ronald B Vender, et al.
Journal of Cutaneous Medicine and Surgery|July 12, 2022
Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 TherapiesJensen Yeung, Paul E Bunce, Charles W Lynde, et al.
Dermatology and Therapy|March 14, 2022
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)Charles W Lynde, Maryam S Alam, Kamal Ohson, et al.
Journal of Drugs in Dermatology : JDD|January 26, 2019
Cohort Using a Ceramides Containing Cleanser and Cream With Salicylic Acid for Dry, Flaking, and Scaling Skin ConditionsRonald B. Vender, Anneke Andriessen, Benjamin Barankin, et al.
Clinical and Experimental Dermatology|August 22, 2024
Predicting psoriasis severity using machine learning: a systematic reviewEric P McMullen, Yousif A Al Naser, Mahan Maazi, et al.
Frontiers in Medicine|July 17, 2023
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, et al.
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque PsoriasisWayne Gulliver, Charles Lynde, Jan P Dutz, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cutaneous Medicine and Surgery|February 6, 2007
Miliarial gout (a new entity)Rahul Shukla, Ronald B Vender, Ayman Alhabeeb, et al.
Journal of the American Academy of Dermatology|June 19, 2007
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapyMichael M Jiaravuthisan, Denis Sasseville, Ronald B Vender, et al.
Journal of Cutaneous Medicine and Surgery|July 12, 2022
Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 TherapiesJensen Yeung, Paul E Bunce, Charles W Lynde, et al.
Dermatology and Therapy|March 14, 2022
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)Charles W Lynde, Maryam S Alam, Kamal Ohson, et al.
Journal of Drugs in Dermatology : JDD|January 26, 2019
Cohort Using a Ceramides Containing Cleanser and Cream With Salicylic Acid for Dry, Flaking, and Scaling Skin ConditionsRonald B. Vender, Anneke Andriessen, Benjamin Barankin, et al.
Clinical and Experimental Dermatology|August 22, 2024
Predicting psoriasis severity using machine learning: a systematic reviewEric P McMullen, Yousif A Al Naser, Mahan Maazi, et al.
Frontiers in Medicine|July 17, 2023
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, et al.
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque PsoriasisWayne Gulliver, Charles Lynde, Jan P Dutz, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Pageof 3